1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Leukemia L 1210 in 1 studies
1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SY | 1 |
| Park, HS | 1 |
| Lee, SJ | 1 |
| Choi, MU | 1 |
1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Leukemia L 1210
| Article | Year |
|---|---|
Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: lack of selective activation of phospholipase A2 by melittin.
Topics: Animals; Arachidonic Acid; Calcium; Cell Line; Cell Membrane Permeability; Cyclohexanones; Digitonin | 2001 |